RHOGAM ANTI-D

DESCRIPTION

RHOGAM ANTI-D – HEMAT

Indications of use

Pregnancy and other obstetrical conditions

RhoGAM is indicated for administration to Rh-negative women not previously sensitized to the Rho(D) factor, unless the father or baby are conclusively Rh-negative, in case of:

•     Delivery of an Rh-positive baby irrespective of the ABO groups of the mother and baby
•     Antepartum prophylaxis at 26 to 28 weeks gestation
•     Antepartum fetal-maternal hemorrhage (suspected or proven) as a result of placenta previa, amniocentesis, chorionic villus sampling, percutaneous umbilical blood sampling, other obstetrical manipulative procedure (e.g., version) or abdominal trauma
•     Actual or threatened pregnancy loss at any stage of gestation
•     Ectopic pregnancy

Transfusion of Rh-incompatible blood or blood products

RhoGAM is indicated for prevention of Rh immunization in any Rh-negative person after incompatible transfusion of Rh-positive blood or blood products (e.g., red blood cells, platelet concentrates, granulocyte concentrates).

CHARACTERISTICS

ACTIVE SUBSTANCE

RHO(D) IMMUNE GLOBULIN

FORM

300 MG

MANUFACTURER

HEMAT